GlassScriptPhysician profile
John R Roberts
NPI 1851380976
$7,222.25
in general payments reported to CMS, 2019-2025
14 companies · $213 in 2025
The $213 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,985 · 2020: $240 · 2021: $263 · 2022: $144 · 2023: $164 · 2024: $213 · 2025: $213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $590.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $590.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $2,075.11 | 2019-2020 | |
| Arthrex, INC. | $1,926.50 | 2019 | |
| Prime Surgical, LLC | $1,166.95 | 2019 | |
| Stryker Corporation | $935.89 | 2019 | |
| Medtronic, INC. | $415.06 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Abbott Laboratories | $369.44 | 2021-2025 | Proclaim, Eterna |
| Stimwave Technologies Incorporated | $108.79 | 2019 | |
| Collegium Pharmaceutical, INC. | $61.21 | 2022-2025 | Xtampza |
| Almatica Pharma LLC | $54.64 | 2021-2022 | |
| Abbvie INC. | $47.43 | 2023-2025 | Botox |
| Averitas Pharma INC. | $21.28 | 2024 | Qutenza |
| Currax Pharmaceuticals LLC | $14.42 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $14.02 | 2023 | Exparel, Zilretta, Iovera |
| Astrazeneca Pharmaceuticals LP | $11.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Roberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.